HITACHI HIGH-TECH AMERICA, INC. RADIATION THERAPY DIVISION
1 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (1)
- Inspections (3)
Devices registered here (1)
- System, Radiation Therapy, Charged-Particle, MedicalProduct code LHN (opens in a new tab) · Class II · Radiology · 21 CFR 892.5050
Recalls & enforcement
- Class IIOngoing2024-05-27During positioning within the system's 3D to 3D matching mode while transferring CBCT images, when the Float Image Selection button is pressed, it may display CBCT images that are insufficient in number.
FDA inspections (3)
- NAI2026-08-07No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices; Radiation Control and Health Safety Act
- VAI2022-03-04Voluntary Action Indicated · Compliance: Devices; Radiation Control and Health Safety Act · citations posted
- NAI2020-03-09No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices; Radiation Control and Health Safety Act · citations posted
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “HITACHI HIGH-TECH AMERICA, INC. RADIATION THERAPY DIVISION (FEI 3003993895) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3003993895-hitachi-high-tech-america-inc-radiation-/
Alerts for HITACHI HIGH-TECH AMERICA, INC. RADIATION THERAPY DIVISION
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.